当前位置:
X-MOL 学术
›
Curr. Pain Headache Rep.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Preventative Treatment of Episodic Migraine in Adults.
Current Pain and Headache Reports ( IF 3.2 ) Pub Date : 2019-09-12 , DOI: 10.1007/s11916-019-0823-8 T Dorosch 1 , C A Ganzer 2 , M Lin 3 , A Seifan 4
中文翻译:
血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在成人发作性偏头痛的预防性治疗中的功效。
更新日期:2019-09-12
Current Pain and Headache Reports ( IF 3.2 ) Pub Date : 2019-09-12 , DOI: 10.1007/s11916-019-0823-8 T Dorosch 1 , C A Ganzer 2 , M Lin 3 , A Seifan 4
Affiliation
Purpose of Review
Systematic review of angiotensin-converting enzyme inhibitors (ACE inhibitors) and angiotensin receptor blockers (ARB) in the prophylactic treatment of adults with migraine. To identify gaps in research and provide guidance for future clinical trials.Recent Findings
A search was completed using PubMed, MEDLINE, Embase, and the Cochrane Library January 1, 1990 through December 31, 2017. The following are keywords used in the search: migraine, migraine prophylaxis/prevention, renin-angiotensin-aldosterone system, RAAS, ACE inhibitors, angiotensin-converting enzyme inhibitors: quinapril, perindopril, ramipril, captopril, enalapril, lisinopril, benazepril, fosinopril. Angiotensin receptor blockers, ARB, angiotensin II receptor antagonists: candesartan cilexetil, irbesartan, olmesartan, valsartan, losartan, azilsartan medoxomil, telmisartan, and eprosartan. The search included randomized controlled trials (RCT), systemic reviews and open-label studies of ACE inhibitors and ARB for the prevention of migraine attacks in adults 18–70 years old. Of 2461 retrieved articles, 18 included RCT, meta-analysis, systemic reviews, or guidelines published on ACE inhibitors or ARB in the prevention of migraine. Three RCT with telmisartan 80 mg, candesartan 16 mg, and enalapril 10 mg, and two open-label trials with lisinopril 5 mg and ramipril 5 mg found a high number of responders with greater than 50 % reduction in migraine attack frequency when compared to a 4-week baseline period. Candesartan was superior to placebo while telmisartan and enalapril were not.Summary
Lipophilic ACE inhibitors and ARBs can be effective prophylactic agents for reduction of migraine frequency in adults. Based on the limited number of published trials and small sample size, they are not recommended as first-line prophylactic agents. However, in populations with co-morbidities such as hypertension, they may be useful as first- or second-line prophylactics. Additional trials following the International Headache Society’s guidelines on RCT are warranted.中文翻译:
血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在成人发作性偏头痛的预防性治疗中的功效。